Maintenance Therapy with Olaparib Shows Strong Benefit in Advanced Ovarian Cancer
20:20 EDT 21 Oct 2018 |
NEJM
Olaparib seems to improve progression-free survival in patients with newly diagnosed advanced ovarian cancer, according to an industry-funded trial presented at the European...
More From BioPortfolio on "Maintenance Therapy with Olaparib Shows Strong Benefit in Advanced Ovarian Cancer"